ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 88

Patient-Clinician Co-Participation in Design of an App for RA Management Via Telehealth Yields an App with High Usability and Acceptance

Rebecca Grainger1,2, Tobias Langlotz3, Hermaleigh Townsley4 and William Taylor1,5, 1University of Otago Wellington, Wellington, New Zealand, 2Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Lower Hutt, New Zealand, 3Department of Information Science, University of Otago, Dunedin, New Zealand, 4Department of Medicine, University of Otago Wellington, Wellington, New Zealand, 5Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Wellington, New Zealand

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: MHealth, patient participation and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Health Services Research - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Traditional management of rheumatoid arthritis (RA) is by rheumatologist review 3 to 6 monthly. This is not sustainable in many healthcare systems as demand exceeds rheumatologist capacity, with these demands projected to increase. Mobile software (an application or app) could enable patients to provide remote monitoring of health status via patient reported outcomes (PROs), patient-performed joint counts and electronic messages to health care professionals (HCP). This worked aimed to 1. Assess opinions of people with RA and HCP regarding design and functionality of an app and acceptability and usefulness of an app assisted telehealth approach for RA 2. Develop an app and 3. Assess usability of the app.

Methods: Semi-structured interviews were undertaken with people with RA (ACR 2010 criteria) and HCP, recruited from a hospital rheumatology service. Interviews explored technology use, app functionality, barriers and facilitators to app use and potential impacts of app implementation on service provision and experience. Thematic analysis was performed and recruitment concluded when saturation achieved. An app (RAConnect) was developed in iOS and android with design and function informed by interview data. People with RA used RAConnect on their mobile devices for one month then usability was assessed (System usability scale) and free text feedback collected.

Results: Nine people with RA (27-79yrs, 7 females, 1-26yrs of RA, low-moderate disease activity) and 11 HCP were interviewed. Four themes were identified 1. Variable app readiness. 2. Reduced barriers with high app usability and text message communication. 3. Pros and cons of PROs, with some ambivalence 4. Resource allocation and engagement – PRO reporting via an App is acceptable to guide HCP in allocation of limited resource while also increasing patient engagement. Usability testing with 16 people with RA confirmed RAConnect had high usability (SUS 80/100, 90th centile). Both the app and a telehealth approach had high acceptability. “I think a wraparound thing like RAConnect would allow better spacing between appointments and for me it would make them less stressful.”48Male “I think that it has the potential to be very useful in managing my RA. It is easy to use and may mean less visits to the rheumatologist.” 49Male. “It’ll be a great tool for both the Doctors, their clinical staff and their patients.” 70Female.

Conclusion: A patient-held app for RA monitoring and communication with rheumatology care provider will be acceptable and desirable for many patients. Further research is required to develop multi-media material to train people with RA to perform joint counts and to validate patient-performed joint counts. During implementation assessment of the patient experience of using this telehealth system, disease outcomes, costs and impact on workflow of HCP will be required.


Disclosure: R. Grainger, None; T. Langlotz, None; H. Townsley, None; W. Taylor, None.

To cite this abstract in AMA style:

Grainger R, Langlotz T, Townsley H, Taylor W. Patient-Clinician Co-Participation in Design of an App for RA Management Via Telehealth Yields an App with High Usability and Acceptance [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/patient-clinician-co-participation-in-design-of-an-app-for-ra-management-via-telehealth-yields-an-app-with-high-usability-and-acceptance/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-clinician-co-participation-in-design-of-an-app-for-ra-management-via-telehealth-yields-an-app-with-high-usability-and-acceptance/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology